Hepion Pharmaceuticals Company
Hepion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of targeted therapies for liver disease.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
Edison, New Jersey, United States
Founded Date:
2013
Employees Number:
11-50
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Register and Claim Ownership